Search

Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments:

… Thursday, July 28, 2022 Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments: Ya-Ting Wang and Inaki Etxberria Ya-Ting “Emma” Wang and Inaki Etxberria Receive Prestigious Early Career Researcher Awards Ya-Ting “Emma” Wang , postdoctoral fellow, was named the 2022

… Monday, December 27, 2021 Building on their long-term shared commitment to international collaboration on cancer research and care – Memorial Sloan Kettering Cancer Center (MSK) and the Chinese Thoracic Oncology Group (CTONG), an alliance of more than 30 premier academic cancer centers in China – joined

Learn how testicular cancer is often misunderstood and why it is highly treatable.

… Thursday, June 29, 2023 Highlights Testicular cancer Testicular cancer is a rare but very curable disease. Testicular cancer strikes younger men (people whose sex assigned at birth was male). An injury to your testicles (getting “hit in the balls”) does not cause testicular cancer.   Many people with

Read about a new treatment for people with some ER+, HER2- advanced breast cancers.

… Friday, December 12, 2025 Updated results from a clinical trial show that a new treatment continues to be effective at stopping advanced breast cancer from progressing in some people with tumors that have grown resistant to standard therapy. The new data also suggests that overall survival can be improved

A small number of cancer cells with the ability to change their identities and behaviors appear to be a key driver of cancer progression and its ability to evolve resistance to treatment, MSK researchers have found in a laboratory study of lung cancer.

… Wednesday, January 21, 2026 A small number of cancer cells with the ability to change their identities and behaviors appear to be a key driver of cancer progression and its ability to evolve resistance to treatment. Targeting this subpopulation of “highly plastic” cells may make current treatments more

Learn about MSK research showing that bacteria inside head and neck tumors can make a difference in their response to immunotherapy.

… Friday, January 2, 2026 In cancer research, failure can lead to an important discovery. That’s what happened when an international multicenter trial led by  MSK radiation oncologist and early drug development specialist Nancy Lee, MD , tried combining radiation and chemotherapy with an immunotherapy

Tumors with a biomarker called high microsatellite instability have been linked to inherited cancer mutations.

… Saturday, June 2, 2018 Summary MSK researchers have found that tumors with a particular genetic marker are likely to be associated with Lynch syndrome. Memorial Sloan Kettering researchers have found that the genetic condition Lynch syndrome may be associated with more cancers than earlier thought. Lynch

MSK researchers developed an artificial intelligence system to detect cancer on digitized microscope slides.

… Monday, July 15, 2019 VIDEO | 00:45 Thomas Fuchs discusses how the computer model uses artificial intelligence to analyze digitized patient slides and detect cancer. Video Details Summary Cancer pathologists can spend hours each day studying slides that may yield little useful information. A type of

Memorial Sloan Kettering Cancer Center (MSK) announces its most recent awards and appointments for the institution’s physicians, scientists, nurses, and staff.

… Tuesday, March 16, 2021 Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments: Chrysothemis Brown Receives a 2021 Parker Institute for Cancer Immunotherapy Award Chrysothemis Brown Chrysothemis (Chryssie) Brown, MBBS, PhD , was recently awarded a 2021 Parker Institute

Memorial Sloan Kettering (MSK) has named three investigators as recipients of this year’s Paul Marks Prize for Cancer Research. The award recognizes promising investigators aged 45 or younger for their efforts in advancing cancer research.

… Tuesday, September 29, 2015 Memorial Sloan Kettering (MSK) has named three investigators as recipients of this year’s  Paul Marks Prize for Cancer Research . The award recognizes promising investigators aged 45 or younger for their efforts in advancing cancer research. The winners are Bradley Bernstein